Viewing Study NCT04837703


Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2026-02-13 @ 7:04 AM
Study NCT ID: NCT04837703
Status: AVAILABLE
Last Update Posted: 2025-12-05
First Post: 2021-04-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: MAP to Provide Access to Eltrombopag, for Treatment of Patients With Medically Significant Thrombocytopenia
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module